Citation Impact
13 by Nobel laureates 51 standout
Citing Papers
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Bispecific and multispecific antibodies in oncology: opportunities and challenges
2024 Standout
Works of Marek Ziobro being referenced
Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non–Clear Cell Renal Cell Carcinoma
2021 Standout
Author Peers
| Author | Oncology | Molecular Biology | PRM | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|
| Marek Ziobro | 263 | 183 | 256 | 42 | 430 | |
| Ryu Maeda | 15 | 586 | 11 | 14 | 712 | |
| Dirk Bröll | 3 | 17 | 10 | 403 | ||
| Sven Mothes | 3 | 17 | 236 | |||
| Beth A. Lalonde | 2 | 729 | 2 | 8 | 751 | |
| Erhard Neher | 1 | 17 | 50 | 636 |
All Works
Login with ORCID to disown or claim papers
Loading papers...